Clinical Trials Directory

Trials / Completed

CompletedNCT01463969

High Plasma Level of Long Pentraxin 3 is Associated With Insulin Resistance in Women With Polycystic Ovary Syndrome (PCOS)

High Plasma Level of Long Pentraxin 3 is Associated With Insulin Resistance in Women With Polycystic Ovary Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Gulhane School of Medicine · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

In the present study, serum pentraxin 3 level and its relationship with insulin resistance were determined in patients with Polycystic Ovary Syndrome (PCOS. It was found that PTX3 level is increased in patients with PCOS and it is positively correlated with HOMA-IR.

Conditions

Timeline

Start date
2010-05-01
Completion
2011-05-01
First posted
2011-11-02
Last updated
2011-11-02

Locations

3 sites across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01463969. Inclusion in this directory is not an endorsement.